Amylyx Pharmaceuticals, Inc.
AMLX • NASDAQ
Amylyx Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Joshua Cohen, with a market cap of $1.9B.
Market Cap$1.9B
Employees384.0
CEOJoshua Cohen
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Amylyx Pharmaceuticals, Inc. FAQ
Common questions about Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026.
Amylyx Pharmaceuticals, Inc. has approximately 384 employees.